Nazneen Rahman has figured out a way to make genetic testing more easily accessible for UK women with ovarian cancer, writes Ed Yong at the Atlantic. Women with BRCA1 or BRCA2 mutations are more likely to respond to certain chemotherapy drugs and PARP inhibitors, but getting tested can be difficult.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.